DNA synthesis in multiple myeloma cells following cell cycle-nonspecific chemotherapy
Alberts, D.S.; Golde, D.W.
Cancer Research 34(11): 2911-2914
1974
ISSN/ISBN: 0008-5472 PMID: 4424360 Document Number: 76196
Document emailed within 1 workday
Related Documents
Dreyfus, F.; Ribrag, V.; Leblond, V.; Ravaud, P.; Melle, J.; Quarre, M.C.; Pillier, C.; Boccaccio, C.; Varet, B. 1995: Detection of malignant B cells in peripheral blood stem cell collections after chemotherapy in patients with multiple myeloma Bone Marrow Transplantation 15(5): 707-711Alberts, D.S.; Durie, B.G.; Salmon, S.E. 1977: Treatment of multiple myeloma in remission with anticancer drugs having cell cycle specific characteristics Cancer Treatment Reports 61(3): 381-388
Torosian, M.H.; Mullen, J.L.; Miller, E.E.; Wagner, K.M.; Stein, T.P.; Buzby, G.P. 1983: Adjuvant, pulse total parenteral nutrition and tumor response to cycle-specific and cycle-nonspecific chemotherapy Surgery 94(2): 291-299
Okubo, H.; Inoue, T.; Kudo, J.; Okumura, Y.; Hayashida, K. 1985: Impaired synthesis of polyclonal immunoglobulin by bone marrow cells in a patient with multiple myeloma Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 48(4): 1083-1089
Ludwig, H.; Fritz, E. 1981: Individualized chemotherapy in multiple myeloma by cytostatic drug sensitivity testing of colony-forming stem cells Anticancer Research 1(6): 329-334
Armelin, H.A.; Armelin, M.C. 1979: Cell cycle regulation in mammalian cells: hormones and commitment to DNA synthesis Archivos de Biologia y Medicina Experimentales 12(3): 319-324
Yu, J.-j.; Shen, X.-j.; Wang, X.-d.; Ju, S.-q. 2013: Effect of miR-202 on the growth of multiple myeloma cells via regulating B cell-activating factor and the underlying mechanism Zhonghua Zhong Liu Za Zhi 35(12): 886-891
Malkovský, M.; Asherson, G.L.; Chandler, P.; Colizzi, V.; Watkins, M.C.; Zembala, M. 1983: Nonspecific inhibitor of DNA synthesis elaborated by T acceptor cells. I. Specific hapten- and I-J-driven liberation of an inhibitor of cell proliferation by Lyt-1-2+ cyclophosphamide-sensitive T acceptor cells armed with a product of Lyt-1+2+-specific suppressor cells Journal of Immunology 130(2): 785-790
Zhou, J.; Wang, W.; Wei, Q.-F.; Feng, T.-M.; Tan, L.-J.; Yang, B.-F. 2007: Effects of arsenic trioxide on voltage-dependent potassium channels and on cell proliferation of human multiple myeloma cells Chinese Medical Journal 120(14): 1266-1269
Lucas, J.J.; Terada, N.; Szepesi, A.; Gelfand, E.W. 1992: Regulation of synthesis of p34cdc2 and its homologues and their relationship to p110Rb phosphorylation during cell cycle progression of normal human T cells Journal of Immunology 148(6): 1804-1811
García Laraña, J.; Díaz Mediavilla, J.; Martínez, R.; Lahuerta, J.J.; Alegre, A.; Odriozola, J.; Sureda, A.; San Miguel, J.; De la Rubia, J.; Escudero, A.; Conde, E.; Bladé, J.; Cabrera, R.; Gastearena, J.; Besalduch, J.; Vidal, M.J.; Hernández, F.; Rifon, J.; Leon, A.; Mataix, R.; Parody, R.; Moraleda, J.M.; Solano, C.; de Pablos, J.M.; Sánchez, J.J. 1997: Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma Sangre 42(Suppl 1): 38-41
Sorenson, C.M.; Eastman, A. 1988: Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells Cancer Research 48(23): 6703-6707
Wang, J.Z.; Tsumura, H.; Shimura, K.; Tian, X.; Ito, H. 1998: Effects of spin labeled derivatives of podophyllotoxin on cell cycle and macromolecular synthesis in human lymphoid leukemia Molt 4B cells Zhongguo Yao Li Xue Bao 19(6): 501-505
Weckbecker, G.; Weckbecker, A.; Lien, E.J.; Cory, J.G. 1987: Effects of N-hydroxy-N'-aminoguanidine derivatives on ribonucleotide reductase activity, nucleic acid synthesis, clonogenicity, and cell cycle of L1210 cells Cancer Research 47(4): 975-978
Ujiie, T. 1987: Effect of an antitumor chelator, 2-(2-hydroxy-5-n-hexylphenyl)-8-quinolinol-4-carboxylic acid (HQ-II) on DNA synthesis, clonogenicity, and cell cycle progression of Hela cells Japanese Journal of Experimental Medicine 57(1): 19-30
Sezaki, T. 1989: Current results of chemotherapy in multiple myeloma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(5): 1997-2003
Tribalto, M.; Arcese, W.; Colombo, R.; Pastore, S.; Franchii, A. 1981: Chemotherapy of multiple myeloma. Review of the recent trials Recenti Progressi in Medicina 71(2): 141-147
Commes, T.; Clofent, G.; Ghanem, N.; Zhang, X.G.; Lefranc, M.P.; Bataille, R.; Klein, B. 1993: Analysis of the B-cell compartment in plasma cell leukemia and multiple myeloma: immunoglobulin gene rearrangement of EBV-infected B-cell lines Leukemia 7(4): 609-617
Takahashi, T.; Makiguchi, Y.; Hinoda, Y.; Kakiuchi, H.; Nakagawa, N.; Imai, K.; Yachi, A. 1994: Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient Journal of Immunology 153(5): 2102-2109
Sung, C.P.; Arleth, A.J.; Eichman, C.; Truneh, A.; Ohlstein, E.H. 1997: Carvedilol, a multiple-action neurohumoral antagonist, inhibits mitogen-activated protein kinase and cell cycle progression in vascular smooth muscle cells Journal of Pharmacology and Experimental Therapeutics 283(2): 910-917